NPi-300 Pupillometer System
Neurological monitoring in critical care (TBI, stroke, cardiac arrest, etc.)
CommercialActive
Key Facts
Indication
Neurological monitoring in critical care (TBI, stroke, cardiac arrest, etc.)
Phase
Commercial
Status
Active
Company
About NeurOptics
NeurOptics is a commercial-stage medical device company and the worldwide leader in automated pupillometry. Its flagship NPi-300 system delivers objective, numerical data on pupil size and reactivity, addressing the critical need for reliable neurological monitoring in intensive care settings. The technology is already adopted in over 1,000 U.S. hospitals and represented in more than 50 countries, indicating strong market validation. The company is positioned at the intersection of medical devices and digital health, with a focus on integrating pupillometry data into electronic medical records to enhance clinical decision-making.
View full company profile